Skip to main content
SpringerLink
Log in

Transmission and control of rhinovirus colds

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

With the expanding knowledge of rhinovirus transmission and rhinovirus chemistry, the outlook for control of infections with these agents has brightened considerably. Although rhinoviruses are probably the world's leading cause of respiratory illness, they are surprisingly reluctant transmitters, infecting only about 50% of susceptibles in family-like settings. Current research suggests that rhinoviruses are spread chiefly by aerosol, rather than by fomites or personal contact. It has been possible to interrupt rhinovirus transmission completely by careful use of virucidal facial tissues, which, presumably, smothered aerosols generated by coughing, sneezing and nose blowing. Accordingly, it may be feasible to control rhinovirus (and perhaps other virus) dissemination by appropriate air handling and filtration systems in combination with careful nasal sanitation. Anti-rhinovirus drug development is also moving forward. Although there are over 100 rhinovirus serotypes, it has been found that most rhinoviruses attach to a single cell receptor by a single binding site on the virus. Also, the structure of the rhinovirus capsid is now known at the atomic level. These two pieces of knowledge about basic viral architecture appear to open new vistas for reasoned synthesis of antiviral drugs, and some promising compounds are now under investigation. Even interferon has been demonstrated useful in a family setting. On several research fronts, there are good grounds for optimism about control of rhinovirus colds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abraham G. and Colonno R. (1984): Many rhinovirus serotypes share the same cellular receptor. -J. Virol., 51: 340–345.

    Google Scholar 

  2. Anderson T. (1979): Vitamin C and the common cold. - J. of the Med. Soc. of New Jersey, 76: 765–766.

    Google Scholar 

  3. Beem M. (1969): Acute respiratory illness in nursery school children: a longitudinal study of the occurrence of illness and repiratory viruses. -Amer. J. Epidemiol., 90: 30–44.

    Google Scholar 

  4. Buckland F., Bynoe M. and Tyrrell D. (1965): Experiments on the spread of colds. II. Studies in volunteers with coxsaekievirus A21. - J. Hyg., Camb., 63: 327–343.

    Google Scholar 

  5. Buckland F. and Tyrrell D. (1964): Experiments on the spread of colds. 1. Laboratory studies on the dispersal of nasal secretion. - J. Hyg., Camb., 62: 365–377.

    Google Scholar 

  6. Cate T. (1978): Self-control of the common cold? -Ann. Intern. Med., 88: 569–570.

    Google Scholar 

  7. Colonno R., Callahan P. and Long W. (1986): Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses. - J. Virol., 57: 7–12.

    Google Scholar 

  8. Couch R. (1984): The common cold: Control? - J. Infect. Dis., 150: 167–173.

    Google Scholar 

  9. Coulehan J. (1979): Ascorbic acid and the common cold. - Postgrad. Med., 66: 153–160.

    Google Scholar 

  10. D'Alessio D., Meschievitz C., Peterson J., Dick C. and Dick E. (1984): Short-duration exposure and the transmission of rhinoviral colds. - J. Infect. Dis., 150: 189–194.

    Google Scholar 

  11. D'Alessio D., Peterson J., Dick C. and Dick E. (1976): Transmission of experimental rhinovirus colds in volunteer married couples. - J. Infect. Dis., 133: 28–36.

    Google Scholar 

  12. De Long D. and Reed S. (1980): Inhibition of rhinovirus replication in organ culture by a potential antiviral drug. - J. Infect. Dis., 141: 87–91.

    Google Scholar 

  13. Dick E. (1968): Experimental infection of chimpanzees with human rhinovirus types 14 and 43. -Proc. Soc. Exp. Biol. and Med., 127: 1079–1081.

    Google Scholar 

  14. Dick E. and Dick C. (1968): A subclinical outbreak of human rhinovirus 31 infection in chimpanzees. -Amer. J. Epidemiol., 88: 267–272.

    Google Scholar 

  15. Dick E. and Dick C. (1974): Natural and experimental infections of nonhuman primates with respiratory viruses. - Lab. Anim. Sci., 24: 177–181.

    Google Scholar 

  16. Dick E., Hossain S., Mink K., Meschievitz C., Schultz S., Raynor W. and Inhorn S. (1986): Interruption of transmission of rhinovirus colds among human volunteers using virucidal paper handkerchiefs. - J. Infect. Dis., 153: 352–356.

    Google Scholar 

  17. Dick E., Jennings L., Meschievitz C., MacMillan D. and Goodrum J. (1980): Possible modification of the normal winter fly-in respiratory disease outbreak at McMurdo Station. - Antarctic J. of the U.S., 15: 173–174.

    Google Scholar 

  18. Dick E., Jennings L., Mink K., Wartgow C. and Inhorn S. (1987): Aerosol transmission of rhinovirus colds. - J. Infect. Dis., 156: 442–448.

    Google Scholar 

  19. Dick E. and Inhorn S. (1987): Rhmoviruses. pp. 1539–1557. In: Feigin R. and Cherry J. Textbook of Pediatric Infectious Diseases. 2nd Edition. W.B. Saunders Company, Philadelphia.

    Google Scholar 

  20. Douglas R., Jr. (1986): The common cold-relief at last? - New Engl. J. Med., 314: 114–115.

    Google Scholar 

  21. Douglas R. Jr., Cate T., Gerone P. and Couch R. (1966): Quantitative rhinovirus shedding patterns in volunteers. - Amer. Rev. Respiratory Dis., 94: 159–167.

    Google Scholar 

  22. Douglas R., Moore B., Miles H., Davies L., Graham N., Ryan P., WorsIvick D. and Albrecht J. (1986): Prophylactic efficacy of intranasal alpha2-interferon against rhinovirus infections in the family setting. - New Engl. J. Med., 314: 65–70.

    Google Scholar 

  23. Eby G., Davis D. and Halcomb W. (1984): Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. - Antimicrob. Agents and Chemotherapy, 25: 20–24.

    Google Scholar 

  24. Fox J., Cooney M., Hall C. and Foy H. (1985): Rhinoviruses in Seattle families, 1975–1979. - Amer. J. of Epidemiol., 122: 830–846.

    Google Scholar 

  25. Foy H., Fox J. and Cooney M. (1986): Efficacy of alpha2- interferon against the common cold. -New Engl. J. Med., 315: 513–514.

    Google Scholar 

  26. Gwaltney J. Jr. (1982): Rhinoviruses. 491–517. In: Evans A. Viral infections of humans. Epidemiology and control. 2nd Edition. Plenum Publishing Corporation, N.Y., N.Y.

    Google Scholar 

  27. Gwaltney J. Jr. and Hendley J. (1982): Transmission of experimental rhinovirus infection by contaminated surfaces. - Amer. J. Epidemiol., 116: 828–833.

    Google Scholar 

  28. Gwaltney J. Jr., Moskalski P. and Hendley J. (1978): Hand-to-hand transmission of rhinovirus colds. - Ann. Intern. Med., 88: 463–467.

    Google Scholar 

  29. Hamparian V., Colonno R., Cooney M., Dick E., Gwaltney J. Jr., Hughes J., Jordan W. Jr., Kapikian A., Mogabgab W., Monto A., Phillips C., Rueckert R., Schieble J., Stott E. and Tyrrell D. (1987): Rhinoviruses: Extension of the numbering system from 89 to 100. - Virology, 159: 191–192.

    Google Scholar 

  30. Hayden F., Albrecht J., Kaiser D. and Gwaltney J. Jr. (1986): Prevention of natural colds by contact prophylaxis with intranasal alpha2- interferon. -New Engl. J. Med., 314: 71–75.

    Google Scholar 

  31. Hayden F. and Gwaltney J. Jr. (1982): Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection. -Antimicrob. Agents and Chemotherapy, 21: 892–897.

    Google Scholar 

  32. Hayden F., Gwaltney J. Jr. and Colonno R. (1986): Effect of rhinovirus receptor monoclonal antibody on the course of experimentally-induced rhinovirus type 39 infection in man. Presented at the 1986 Annual Meeting of the American Society for Virology, June 22–26, in Santa Barbara, Calif.

  33. Hendley J., Wenzel R. and Gwaltney J. Jr. (1973): Transmission of rhinovirus colds by self-inoculation.- New Engl. J. Med., 288: 1361–1364.

    Google Scholar 

  34. Holmes M., Reed S., Stott E. and Tyrrell D. (1976): Studies of experimental rhinovirus type 2 infections in polar isolation and in England. - J. Hyg., Camb., 76: 379–393.

    Google Scholar 

  35. Isaacs A. and Lindenmann J. (1957): Interference. I. The Interferon. - Proc. Roy. Soc., Ser. B., 147: 258–267.

    Google Scholar 

  36. Korant B. and Butterworth B. (1976): Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. - J. Virol., 18:: 298–306.

    Google Scholar 

  37. Krilov L., Pierik L., Keller E., Mahan K., Watson D., Hirsch M., Hamparian V. and McIntosh K. (1986): The association of rhinoviruses with lower respiratory tract disease in hospitalized patients. -J. Med. Virol., 19: 345–352.

    Google Scholar 

  38. McKinley M. and Steinberg B. (1986): Oral efficacy of WIN 51711. in mice infected with human poliovirus.- Antimicrob. Agents and Chemotherapy, 29: 30–32.

    Google Scholar 

  39. Meschievitz C., Schultz S. and Dick E. (1984): A model for obtaining predictable natural transmission of rhinoviruses in human volunteers. - J. Infect. Dis., 150: 195–201.

    Google Scholar 

  40. Minor T., Dick E., De Meo A., Ouellette J., Cohen M. and Reed C. (1974): Viruses as precipitants of asthmatic attacks in children. - J. Amer. Med. Ass., 227: 292–298.

    Google Scholar 

  41. Monto A. (1968): A community study of respiratory infections in the tropics. III. Introduction and transmission of infections within families. - Amer. J. of Epidemiol., 88: 69–79.

    Google Scholar 

  42. Monto A. and Cavallaro J. (1972): The Tecumseh study of respiratory illness. IV. Prevalence of rhinovirus serotypes, 1966–1969. - Amer. J. of Epidemiol., 96: 352–360.

    Google Scholar 

  43. Otto M., Fox M., Fancher M., Kuhrt M., Diana G. and McKinley M. (1985): In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug. - Antimicrob. Agents and Chemotherapy, 27: 883–886.

    Google Scholar 

  44. Pauling L. (1986): How to live longer and feel better. W.H. Freeman and Company, N.Y., N.Y.

    Google Scholar 

  45. Phillpotts R., Delong D., Wallace J., Jones R., Reed S. and Tyrrell D. (1981): The activity of enviroxime against rhinovirus infection in man. - Lancet, 1: 1342–1344.

    Google Scholar 

  46. Phillpotts R., Wallace J., Tyrrell D. and Tagart V. (1983): Therapeutic activity of enviroxime against rhinovirus infection in volunteers. - Antimicrob. Agents and Chemotherapy, 23: 671–675.

    Google Scholar 

  47. Reed S. (1975): An investigation of the possible transmission of rhinovirus colds through indirect contact. - J. Hyg., Camb., 75: 249–258.

    Google Scholar 

  48. Rossmann M., Arnold E., Erickson J., Frankenberger E., Griffith J., Hecht H., Johnson J., Kamer G., Luo M., Mosser A., Rueckert R., Sherry B. and. Vriend G. (1985): Structure of a human common cold virus and functional relationship to other picornaviruses. - Nature, 317: 145–153.

    Google Scholar 

  49. Rueckert R., Sherry B., Mosser A., Colonno R. and Rossmann M. (1986): Location of four neutralization antigens on the three-dimensional surface of a common-cold picornavirus, human rhinovirus 14. pp. 21–27. In: Crowell R. and Lonberg-Holm K. Virus attachment and entry into cells. -Amer. Soc. for Microbiol., Washington, DC.

    Google Scholar 

  50. Shipkowitz N., Bower R., Schleicher J., Aquino F., Appell R. and Roderick W. (1972): Antiviral activity of a bis-Benzimidazole against experimental rhinovirus infections in chimpanzees. - Appl. Microbiol., 23: 117–122.

    Google Scholar 

  51. Smith T., Kremer M., Luo M., Vriend G., Arnold E., Kamer G., Rossmann M., McKinlay M., Diana G. and Otto M. (1986): The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. - Science, 233: 1286–1293.

    Google Scholar 

  52. Wikel J., Paget C., De Long D., Nelson J., Wu Y., Paschal J., Dinner A., Templeton R., Chaney M., Jones N. and Chainberlin J. (1980): Synthesis of syn- and anti-isomers of 6-[[(Hydroxyimino) phenyl-methyl]-1-[(methylethyl) sulfonyl]-1 H-benzimi dazol-2-amine. Inhibitors of rhinovirus multiplication, J. Med. Chem., 23: 368–372.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Preventive Medicine, University of Wisconsin Medical School, Stovall Building, 465 Henry Mall, 53706, Madison, Wisconsin

    L. C. Jennings & E. C. Dick

Authors
  1. L. C. Jennings
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. C. Dick
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jennings, L.C., Dick, E.C. Transmission and control of rhinovirus colds. Eur J Epidemiol 3, 327–335 (1987). https://doi.org/10.1007/BF00145641

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00145641

Key words

Search

Navigation